Search Results - Chang, Gee-Chen
- Showing 1 - 3 results of 3
-
1
Amivantamab plus lazertinib in previously untreated EGFR-mutated advanced NSCLC by Cho, Byoung C. (Author) , Lu, Shun (Author) , Felip, Enriqueta (Author) , Spira, Alexander I. (Author) , Girard, Nicolas (Author) , Lee, Jong-Seok (Author) , Lee, Se-Hoon (Author) , Ostapenko, Yurii (Author) , Danchaivijitr, Pongwut (Author) , Liu, Baogang (Author) , Alip, Adlinda (Author) , Korbenfeld, Ernesto (Author) , Mourão Dias, Josiane (Author) , Besse, Benjamin (Author) , Lee, Ki-Hyeong (Author) , Xiong, Hailin (Author) , How, Soon-Hin (Author) , Cheng, Ying (Author) , Chang, Gee-Chen (Author) , Yoshioka, Hiroshige (Author) , Yang, James C.-H. (Author) , Thomas, Michael (Author) , Nguyen, Danny (Author) , Ou, Sai-Hong I. (Author) , Mukhedkar, Sanjay (Author) , Prabhash, Kumar (Author) , D'Arcangelo, Manolo (Author) , Alatorre-Alexander, Jorge (Author) , Vázquez Limón, Juan C. (Author) , Alves, Sara (Author) , Stroyakovskiy, Daniil (Author) , Peregudova, Marina (Author) , Şendur, Mehmet A. N. (Author) , Yazici, Ozan (Author) , Califano, Raffaele (Author) , Gutiérrez Calderón, Vanesa (Author) , de Marinis, Filippo (Author) , Passaro, Antonio (Author) , Kim, Sang-We (Author) , Gadgeel, Shirish M. (Author) , Xie, John (Author) , Sun, Tao (Author) , Martinez, Melissa (Author) , Ennis, Mariah (Author) , Fennema, Elizabeth (Author) , Daksh, Mahesh (Author) , Millington, Dawn (Author) , Leconte, Isabelle (Author) , Iwasawa, Ryota (Author) , Lorenzini, Patricia (Author) , Baig, Mahadi (Author) , Shah, Sujay (Author) , Bauml, Joshua M. (Author) , Shreeve, S. Martin (Author) , Sethi, Seema (Author) , Knoblauch, Roland E. (Author) , Hayashi, Hidetoshi (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
2
A randomized-controlled phase 2 study of the MET antibody emibetuzumab in combination with erlotinib as first-line treatment for EGFR mutation-positive NSCLC patients by Scagliotti, Giorgio V. (Author) , Moro-Sibilot, Denis (Author) , Kollmeier, Jens (Author) , Favaretto, Adolfo (Author) , Cho, Eun Kyung (Author) , Grosch, Heidrun (Author) , Kimmich, Martin (Author) , Girard, Nicolas (Author) , Tsai, Chun-Ming (Author) , Hsia, Te-Chun (Author) , Brighenti, Matteo (Author) , Schumann, Christian (Author) , Wang, Xuejing Aimee (Author) , Wijayawardana, Sameera R. (Author) , Gruver, Aaron M. (Author) , Wallin, Johan (Author) , Mansouri, Kambiz (Author) , Wacheck, Volker (Author) , Chang, Gee-Chen (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource -
3
Tepotinib in non-small-cell lung cancer with MET Exon 14 skipping mutations by Paik, Paul K. (Author) , Felip, Enriqueta (Author) , Veillon, Remi (Author) , Sakai, Hiroshi (Author) , Cortot, Alexis B. (Author) , Garassino, Marina C. (Author) , Mazieres, Julien (Author) , Viteri, Santiago (Author) , Senellart, Helene (Author) , Meerbeeck, Jan van (Author) , Raskin, Jo (Author) , Reinmuth, Niels (Author) , Conte, Pierfranco (Author) , Kowalski, Dariusz (Author) , Cho, Byoung Chul (Author) , Patel, Jyoti D. (Author) , Horn, Leora (Author) , Griesinger, Frank (Author) , Han, Ji-Youn (Author) , Kim, Young-Chul (Author) , Chang, Gee-Chen (Author) , Tsai, Chen-Liang (Author) , Yang, James C.-H. (Author) , Chen, Yuh-Min (Author) , Smit, Egbert F. (Author) , Wekken, Anthonie J. van der (Author) , Kato, Terufumi (Author) , Juraeva, Dilafruz (Author) , Stroh, Christopher (Author) , Bruns, Rolf (Author) , Straub, Josef (Author) , Johne, Andreas (Author) , Scheele, Jürgen Sylvius (Author) , Heymach, John V. (Author) , Le, Xiuning (Author) ,
Call Number: Loading…
Located: Loading…
Article (Journal) Online Resource
Search Tools:
Related Subjects
Acquired resistance
Acrylamides
Adult
Aged
Aged, 80 and over
Aniline Compounds
Antibodies, Bispecific
Antibody
Antineoplastic Agents, Immunological
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Non-Small-Cell Lung
ErbB Receptors
Female
First-line mutation
Humans
Kaplan-Meier Estimate
Lung Neoplasms
MET
Male
Middle Aged
Morpholines
Mutation
NSCLC
Progression-Free Survival
Protein Kinase Inhibitors
Pyrazoles
Pyrimidines
Quinolines
Treatment Outcome